Results 11 to 20 of about 18,698 (311)

Rhodotorula mucilaginosa Fungemia, a Rare Opportunistic Infection without Central Venous Catheter Implantation, Successfully Treated by Liposomal Amphotericin B

Case Reports in Infectious Diseases, 2022
Background. Fungemia due to Rhodotorula mucilaginosa is rare and highly resistance to antifungal therapy. Since most cases of R. mucilaginosa fungemia are attributed to medical devices, limited information is currently available on infection without ...
Ryuichi Hirano, Tatsuro Mitsuhashi, Katsuyoshi Osanai   +2 more
doaj   +2 more sources

Fungemia in Hospitalized Adult Patients with Hematological Malignancies: Epidemiology and Risk Factors

Journal of Fungi, 2023
Fungemia in hematologic malignancies (HM) has high mortality. This is a retrospective cohort of adult patients with HM and fungemia between 2012 and 2019 in institutions of Bogotá, Colombia.
Luz Alejandra Vargas-Espíndola, Sonia I. Cuervo-Maldonado, José L. Enciso-Olivera, Julio C. Gómez-Rincón, Leydy Jiménez-Cetina, Ricardo Sánchez-Pedraza, Katherine García-Guzmán, María José López-Mora, Carlos A. Álvarez-Moreno, Jorge Alberto Cortés, Javier R. Garzón-Herazo, Samuel Martínez-Vernaza, Claudia R. Sierra-Parada, Bryan A. Murillo-Sarmiento   +13 more
doaj   +2 more sources

Characteristics of fungemia in a peruvian referral center: 5-year retrospective analysis

Revista Peruana de Medicina Experimental y Salud Pública, 2020
Retrospective descriptive study carried out to determine the characteristics of fungemia in 285 cancer patients hospitalized from 2012 to 2016 at the Instituto Nacional de Enfermedades Neoplásicas (INEN).
Freddy Villanueva, Janet Veliz, Karol Canasa Calvo, Esther Bellido, Shirley Martell, Sherly Ortega, Ines Cajamarca   +6 more
doaj   +2 more sources

Fungemia and Other Fungal Infections Associated with Use of Saccharomyces boulardii Probiotic Supplements

Emerging Infectious Diseases, 2021
Because of widespread use of probiotics, their safety must be guaranteed. We assessed use of Saccharomyces boulardii probiotic yeast from medical records for patients who had Saccharomyces fungemia or other clinical Saccharomyces culture findings.
Juha Rannikko, Ville Holmberg, Matti Karppelin, Pertti Arvola, Reetta Huttunen, Eero Mattila, Niina Kerttula, Teija Puhto, Ülle Tamm, Irma Koivula, Risto Vuento, Jaana Syrjänen, Ulla Hohenthal   +12 more
doaj   +2 more sources

Saccharomyces cerevisiae fungemia in a critically ill patient with acute cholangitis and long term probiotic use

Medical Mycology Case Reports, 2019
Saccharomyces cerevisiae has recently been used as an ingredient in probiotic supplements. Invasive Saccharomyces infection have been documented, and multiple predisposing risk factors have been identified including critical illness, ICU admission ...
Mustafa Fadhel, Swapnil Patel, Edward Liu, Michael Levitt, Arif Asif   +4 more
doaj   +2 more sources

Impact of the COVID-19 Pandemic on the Clinical Profile of Candidemia and the Incidence of Fungemia Due to Fluconazole-Resistant Candida parapsilosis

Journal of Fungi, 2022
Severely ill COVID-19 patients are at high risk of nosocomial infections. The aim of the study was to describe the characteristics of candidemia during the pre-pandemic period (January 2019–February 2020) compared to the pandemic period (March 2020 ...
A. Ramos-Martínez, I. Pintos-Pascual, J. Guinea, A. Gutiérrez-Villanueva, Edith Gutiérrez-Abreu, Judith Díaz-García, Á. Asensio, R. Iranzo, I. Sánchez‐Romero, María Muñoz-Algarra, V. Moreno-Torres, J. Calderón-Parra, E. Múñez, A. Fernández‐Cruz   +13 more
semanticscholar   +1 more source

Hospital-onset bacteremia and fungemia: An evaluation of predictors and feasibility of benchmarking comparing two risk-adjusted models among 267 hospitals

Infection control and hospital epidemiology, 2022
Objectives: To evaluate the prevalence of hospital-onset bacteremia and fungemia (HOB), identify hospital-level predictors, and to evaluate the feasibility of an HOB metric.
Kalvin C. Yu, Gang Ye, J. Edwards, Vikas Gupta, A. Benin, Chin-En Ai, Raymund B. Dantes   +6 more
semanticscholar   +1 more source

Factors Associated with Breakthrough Fungemia Caused by Candida, Trichosporon, or Fusarium Species in Patients with Hematological Disorders

Antimicrobial Agents and Chemotherapy, 2022
Limited data are available on breakthrough fungemia, defined as fungemia that develops on administration of antifungal agents, in patients with hematological disorders.
M. Kimura, Y. Asano‐Mori, T. Sakoh, M. Abe, Keigo Ueno, Yasutaka Hoshino, Shigeki Nakamura, T. Umeyama, S. Yamagoe, Y. Miyazaki, Masaru Baba, Chikako Okada, Sho Ogura, Takashi Mitsuki, K. Yamaguchi, M. Yuasa, D. Kaji, K. Kageyama, A. Nishida, Yuki Taya, K. Ishiwata, S. Takagi, Hisashi Yamamoto, G. Yamamoto, N. Uchida, A. Wake, S. Taniguchi, H. Araoka   +27 more
semanticscholar   +1 more source

Scedosporium prolificans Fungemia [PDF]

Canadian Journal of Infectious Diseases and Medical Microbiology, 1998
Fungemia due to Scedosporium prolificans is described in a young woman with a relapse of acute lymphoblastic leukemia. Several days after starting reinduction chemotherapy, the patient presented with fever, neutropenia and blood cultures showing fungi on Gram stain.
Sameer Elsayed, Ian Chin-Yee, Robert Lannigan   +2 more
openaire   +4 more sources

[First Case of COVID-19 Positive Candida auris Fungemia in Turkey].

Mikrobiyoloji Bulteni, 2021
Candida auris is a species of fungus that has gained importance in recent years owing to its ability to cause hospital infections and epidemics, resistant to antifungal agents and disinfection processes and frequently misidentified by commercial systems.
Yasemin Bölükbaşı, Gonca Erköse Genç, G. Orhun, M. Kuşkucu, A. Çağatay, M. Önel, B. Öngen, A. Ağaçfidan, F. Esen, Z. Erturan   +9 more
semanticscholar   +1 more source